Literature DB >> 3055212

Role of the capsule in phagocytosis of Cryptococcus neoformans.

T R Kozel1, G S Pfrommer, A S Guerlain, B A Highison, G J Highison.   

Abstract

The capsule is closely associated with the virulence of Cryptococcus neoformans. The capsule inhibits phagocytosis by macrophages, monocytes, and neutrophils. Studies in our laboratory have shown that incubation of encapsulated cryptococci in normal human serum leads to deposition of large amounts of C3 fragments at the surface of the yeast and lesser amounts of IgG within the capsule. Thus, the capsule mediates two biologic activities with opposing effects. It is our current view that phagocytosis of the yeast is dependent on a balance between the antiphagocytic action of cryptococcal polysaccharide and the ability of the yeast to focus opsonically active complement fragments and the IgG at the capsular surface.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3055212     DOI: 10.1093/cid/10.supplement_2.s436

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  58 in total

Review 1.  The Jeremiah Metzger Lecture. Microbial defenses against killing by phagocytes.

Authors:  G L Mandell; M O Frank
Journal:  Trans Am Clin Climatol Assoc       Date:  1992

2.  Mutation of the regulator of G protein signaling Crg1 increases virulence in Cryptococcus neoformans.

Authors:  Ping Wang; Jim Cutler; Jill King; Daniel Palmer
Journal:  Eukaryot Cell       Date:  2004-08

Review 3.  Role of phagocytosis in the virulence of Cryptococcus neoformans.

Authors:  Maurizio Del Poeta
Journal:  Eukaryot Cell       Date:  2004-10

4.  Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection.

Authors:  David O Beenhouwer; Esther M Yoo; Chun-Wei Lai; Miguel A Rocha; Sherie L Morrison
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

5.  Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans.

Authors:  Ryan M Kelly; Jianmin Chen; Lauren E Yauch; Stuart M Levitz
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

6.  In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis.

Authors:  Karen L Wozniak; Jatin M Vyas; Stuart M Levitz
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

7.  Estimating the relative contributions of virulence factors for pathogenic microbes.

Authors:  Erin E McClelland; Paul Bernhardt; Arturo Casadevall
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

8.  Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody.

Authors:  D L Goldman; S C Lee; A Casadevall
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsule.

Authors:  A S Ibrahim; S G Filler; M S Alcouloumre; T R Kozel; J E Edwards; M A Ghannoum
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

10.  Antibody action after phagocytosis promotes Cryptococcus neoformans and Cryptococcus gattii macrophage exocytosis with biofilm-like microcolony formation.

Authors:  Mauricio Alvarez; Carolyn Saylor; Arturo Casadevall
Journal:  Cell Microbiol       Date:  2008-04-01       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.